William Dahut

Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy

K. Pienta, P. Choyke, J. Eary, 2021, The Journal of Nuclear Medicine.

420 PROSTVAC in combination with nivolumab enhanced immune cell infiltration in prostate cancer

P. Pinto, A. Papanicolau‐Sengos, R. Madan, 2021, Journal for ImmunoTherapy of Cancer.

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

S. Ambs, S. Srivastava, I. Sesterhenn, 2018, Prostate Cancer and Prostatic Diseases.

Inhibition of Angiogenesis: Treatment Options for Patients with Metastatic Prostate Cancer

W. Figg, D. Price, E. Kruger, 2002, Investigational New Drugs.

Reversible sideroblastic anemia associated with the tetracycline analogue COL‐3

M. Rudek, W. Figg, E. Reed, 2001, American journal of hematology.

Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer.

S. Libutti, S. Bacharach, K. Kurdziel, 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.